Pentwater Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,625,000	Closed	-$82.8M	–	95
2024 Q4	$82.8M	Buy	8,625,000 +2,650,000	+44%	+$25.4M	0.91%	16
2024 Q3	$17.1M	Hold	5,975,000	–	–	0.18%	29
2024 Q2	$17.4M	Hold	5,975,000	–	–	0.22%	28
2024 Q1	$19.1M	Hold	5,975,000	–	–	0.2%	25
2023 Q4	$20.1M	Hold	5,975,000	–	–	0.23%	30
2023 Q3	$14.2M	Hold	5,975,000	–	–	0.08%	25
2023 Q2	$10.5M	Hold	5,975,000	–	–	0.07%	34
2023 Q1	$18.4M	Hold	5,975,000	–	–	0.18%	41
2022 Q4	$31.7M	Hold	5,975,000	–	–	0.56%	27
2022 Q3	$21.1M	Buy	5,975,000 +1,007,773	+20%	+$3.56M	0.24%	41
2022 Q2	$12.8M	Hold	4,967,227	–	–	0.15%	46
2022 Q1	$22.3M	Hold	4,967,227	–	–	0.27%	36
2021 Q4	$33.8M	Hold	4,967,227	–	–	0.37%	23
2021 Q3	$36.2M	Hold	4,967,227	–	–	0.37%	31
2021 Q2	$49.8M	Hold	4,967,227	–	–	0.41%	26
2021 Q1	$47.4M	Hold	4,967,227	–	–	0.45%	27
2020 Q4	$54.5M	Buy	4,967,227 +87,737	+2%	+$962K	0.66%	21
2020 Q3	$43.3M	Buy	+4,879,490	New	+$43.3M	0.56%	27